From: Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer
 | Luminal-A, n = 175(%) | Luminal-HER2, n = 34(%) | HER2-enriched, n = 41(%) | TNBC, n = 62(%) | P |
---|---|---|---|---|---|
Age | Â | Â | Â | Â | 0.07 |
   ≤ 35 | 11(6.3) | 7(20.6) | 3(7.1) | 6(9.7) |  |
   > 35 | 164(93.7) | 27(79.4) | 39(92.9) | 56(90.3) |  |
Menopausal state, n = 299 | Â | Â | Â | Â | 0.07 |
   Premenopause | 102 | 18 | 17 | 27 |  |
   Menopause | 65 | 16 | 24 | 30 |  |
Tumor size, n = 309 | Â | Â | Â | Â | 0.73 |
   ≤ 5 cm | 158(90.8) | 31(91.2) | 35(85.4) | 55(91.7) |  |
   > 5 cm | 16(9.2) | 3(8.8) | 6(14.6) | 5(8.3) |  |
Nodal status, n = 306 | Â | Â | Â | Â | 0.59 |
   Negative | 95(54.9) | 15(44.1) | 25(59.5) | 31(54.4) |  |
   Positive | 78(45.1) | 19(55.9) | 17(40.5) | 26(45.6) |  |
Operation type | Â | Â | Â | Â | 0.13 |
   BCS | 22(12.6) | 1(2.9) | 2(4.8) | 3(4.8) |  |
   Mastectomy | 153(87.4) | 33(97.1) | 40(95.2) | 59(95.2) |  |
Lymphovascular invasion | Â | Â | Â | Â | 0.42 |
   Absent | 90(51.4) | 17(50.0) | 23(54.8) | 25(40.3) |  |
   Present | 85(48.6) | 17(50.0) | 19(45.2) | 37(59.7) |  |
Systemic therapy, n = 311 | Â | Â | Â | Â | 0.26 |
   None | 3(1.7) | 1(2.9) | 0 | 2(3.3) |  |
   Done | 172(98.3) | 33(97.1) | 41(100) | 59(96.7) |  |
Radiation, n = 309 | Â | Â | Â | Â | 0.36 |
   None | 148(85.1) | 30(90.9) | 37(88.1) | 56(93.3) |  |
   Done | 26(14.9) | 3(9.1) | 5(11.9) | 4(6.7) |  |
Overall survival events | 31(17.7) | 11(32.4) | 13(31.0) | 15(24.2) | 0.11 |